Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.
Riley J, Deng M, Sinha T, Lai M, Jiang S, Kong H, Cooper V, Gu M, Perelman J, Zhang C, Hanindya C, Carpio V, Keller P, Jadlowsky J, Leskowitz R, McKenna S, Four M, Barranco J, Cooper N, Jain A, Gohil M, Haines K, Gerique L, Russell A, Kulikovskaya I, Gonzalez V, Fraietta J, Plesa G, Sheppard N, Davis M, Chew A, Frey N, June C, Svoboda J, Hexner E.
Riley J, et al. Among authors: gonzalez v.
Res Sq [Preprint]. 2026 Feb 4:rs.3.rs-8436008. doi: 10.21203/rs.3.rs-8436008/v1.
Res Sq. 2026.
PMID: 41674825
Free PMC article.
Preprint.